PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW122600View Pathway |
Threonine BiosynthesisPseudomonas aeruginosa
The biosynthesis of threonine starts with oxalacetic acid interacting with an L-glutamic acid through an aspartate aminotransferase resulting in a oxoglutaric acid and an L-aspartic acid. The latter compound is then phosphorylated by an ATP driven Aspartate kinase resulting in an a release of an ADP and an L-aspartyl-4-phosphate. L-aspartyl-4-phosphate then interacts with a hydrogen ion through an NADPH driven aspartate semialdehyde dehydrogenase resulting in the release of a phosphate, an NADP and a L-aspartate-semialdehyde. The latter compound interacts with a hydrogen ion through a NADPH driven aspartate kinase / homoserine dehydrogenase resulting in the release of an NADP and a L-homoserine. L-homoserine is phosphorylated through an ATP driven homoserine kinase resulting in the release of an ADP, a hydrogen ion and a O-phosphohomoserine. O-phosphohomoserine then interacts with a water molecule and threonine synthase resulting in the release of a phosphate and an L-threonine.
|
Creator: Ana Marcu Created On: August 12, 2019 at 18:21 Last Updated: August 12, 2019 at 18:21 |
PW000817View Pathway |
Threonine BiosynthesisEscherichia coli
The biosynthesis of threonine starts with oxalacetic acid interacting with an L-glutamic acid through an aspartate aminotransferase resulting in a oxoglutaric acid and an L-aspartic acid. The latter compound is then phosphorylated by an ATP driven Aspartate kinase resulting in an a release of an ADP and an L-aspartyl-4-phosphate. L-aspartyl-4-phosphate then interacts with a hydrogen ion through an NADPH driven aspartate semialdehyde dehydrogenase resulting in the release of a phosphate, an NADP and a L-aspartate-semialdehyde. The latter compound interacts with a hydrogen ion through a NADPH driven aspartate kinase / homoserine dehydrogenase resulting in the release of an NADP and a L-homoserine. L-homoserine is phosphorylated through an ATP driven homoserine kinase resulting in the release of an ADP, a hydrogen ion and a O-phosphohomoserine. O-phosphohomoserine then interacts with a water molecule and threonine synthase resulting in the release of a phosphate and an L-threonine.
|
Creator: miguel ramirez Created On: March 23, 2015 at 20:54 Last Updated: March 23, 2015 at 20:54 |
PW122449View Pathway |
Threonine BiosynthesisSaccharomyces cerevisiae
|
Creator: Maïlys Paccoud Created On: April 11, 2019 at 15:02 Last Updated: April 11, 2019 at 15:02 |
PW002401View Pathway |
Threonine MetabolismSaccharomyces cerevisiae
The biosynthesis of threonine starts with L-aspartic acid being phosphorylated by an ATP-driven aspartate kinase resulting in a release of an ADP and an L-aspartyl-4-phosphate. This compound interacts with a hydrogen ion through an NADPH-driven aspartate semialdehyde dehydrogenase resulting in the release of a phosphate, an NADP, and an L-aspartate-semialdehyde. The latter compound interacts with a hydrogen ion through an NADPH-driven aspartate kinase / homoserine dehydrogenase resulting in the release of an NADP and an L-homoserine. L-Homoserine is phosphorylated through an ATP driven homoserine kinase resulting in the release of an ADP, a hydrogen ion, and an O-phosphohomoserine. The latter compound then interacts with a water molecule threonine synthase resulting in the release of a phosphate and an L-threonine. L-threonine is degraded into glycine and acetaldehyde by reacting with a threonine aldolase. Acetaldehyde can then be integrated into the mitochondria or stay in the cytosol. It is then degraded into acetyl-CoA through an aldehyde dehydrogenase.
|
Creator: miguel ramirez Created On: January 07, 2016 at 10:05 Last Updated: January 07, 2016 at 10:05 |
PW002554View Pathway |
Threonine MetabolismArabidopsis thaliana
The biosynthesis of threonine starts with L-aspartic acid being phosphorylated by an ATP-driven aspartate kinase resulting in a release of an ADP and an L-aspartyl-4-phosphate. This compound interacts with a hydrogen ion through an NADPH-driven aspartate semialdehyde dehydrogenase resulting in the release of a phosphate, an NADP, and an L-aspartate-semialdehyde. The latter compound interacts with a hydrogen ion through an NADPH-driven aspartate kinase / homoserine dehydrogenase resulting in the release of an NADP and an L-homoserine. L-Homoserine is phosphorylated through an ATP driven homoserine kinase resulting in the release of an ADP, a hydrogen ion, and an O-phosphohomoserine. The latter compound then interacts with a water molecule threonine synthase resulting in the release of a phosphate and an L-threonine. L-threonine is degraded into glycine and acetaldehyde by reacting with a threonine aldolase. Acetaldehyde can then be integrated into the mitochondria or stay in the cytosol. It is then degraded into acetyl-CoA through an aldehyde dehydrogenase.
|
Creator: miguel ramirez Created On: May 27, 2016 at 13:49 Last Updated: May 27, 2016 at 13:49 |
PW128498View Pathway |
drug action
Thrombin Alfa Action PathwayHomo sapiens
Thrombin alfa also known under the brand name Recothrom, is a platelet-activating factor to treat minor bleeding. It is administered topically, it is a recombinant thrombin identical to that of the endogenous human thrombin. Thrombin alfa is a human serine protease that cleaves fibrinogen to fibrin which leads to clot formation. Once thrombin alfa has performed its function it is rapidly inactivated by circulating endogenous plasma inhibitors.
|
Creator: Selena Created On: August 31, 2023 at 17:51 Last Updated: August 31, 2023 at 17:51 |
PW128496View Pathway |
drug action
Thrombin Alfa Action Pathway (didnt work)Homo sapiens
Thrombin alfa also known under the brand name Recothrom, is a platelet-activating factor to treat minor bleeding. It is administered topically, it is a recombinant thrombin identical to that of the endogenous human thrombin. Thrombin alfa is a human serine protease that cleaves fibrinogen to fibrin which leads to clot formation. Once thrombin alfa has performed its function it is rapidly inactivated by circulating endogenous plasma inhibitors.
|
Creator: Selena Created On: August 31, 2023 at 17:28 Last Updated: August 31, 2023 at 17:28 |
PW129677View Pathway |
Thrombopoietin Drug MetabolismHomo sapiens
|
Creator: Selena Created On: September 14, 2023 at 19:26 Last Updated: September 14, 2023 at 19:26 |
PW145509View Pathway |
drug action
Thymol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:58 Last Updated: October 07, 2023 at 15:58 |
PW122317View Pathway |
thyroidHomo sapiens
|
Creator: Wei Zhong Created On: December 20, 2018 at 07:22 Last Updated: December 20, 2018 at 07:22 |